Inhibition of herpes simplex virus type 1 replication by novel hsa-miR-7704 in vitro

Herpes simplex virus type 1 (HSV-1) infections are one of the most common diseases in human population. HSV-1 causes subclinical, mild to severe diseases, especially in immunocompromised patients. Acyclovir has been used to reduce manifestations of HSV-1 infections. The extensive use of this drug ha...

詳細記述

保存先:
書誌詳細
出版年:Res Pharm Sci
主要な著者: Shabani, Mehdi, Nasr Esfahani, Bahram, Sadegh Ehdaei, Bahar, Moghim, Sharareh, Mirzaei, Arezoo, Sharifi, Mohammadreza, Mouhebat, Leili
フォーマット: Artigo
言語:Inglês
出版事項: Wolters Kluwer - Medknow 2019
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791169/
https://ncbi.nlm.nih.gov/pubmed/31620193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-5362.253364
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料